Relsys International provides drug safety and pharmacovigilance software solutions in North America, Europe, Japan, and India. The company offers Argus Safety, an adverse event reporting system that offers regulatory reporting and drug safety database in pharmaceutical industry. Its Argus Safety Modules include Argus Safety Suite, a solution for integrated drug safety and risk management; Argus Affiliate that resolves obstacles for pharmaceutical companies; Argus Assurance that provides systematic pharmacovigilance data; and Argus Beacon, which delivers key performance indicators and metrics from various components of the Argus suite, enabling managers to keep their finger on the pulse of the drug safety and risk management organization. The companyâ€™s Argus Safety Modules also encompass Argus Dossier that allows pharmaceutical enterprises to manage the lifecycle of PSUR dossiers; Argus Insight, a visionary tool for multi-dimensional analysis of drug safety data; and Argus Interchange that exchanges data electronically with partners and regulators.
Oracle acquires Relsys International (tradingmarkets.com)